about
Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver InjuryIdiosyncratic adverse drug reactions: current conceptsSevere sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting systemThe Role of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Treatment of Patients With Hepatic Disease: A Review ArticleDevelopment of a convenient in vivo hepatotoxin assay using a transgenic zebrafish line with liver-specific DsRed expressionA systematic review of agomelatine-induced liver injuryThe characteristics and clinical outcome of drug-induced liver injury in a Chinese hospital: A retrospective cohort study.The Effects of Melatonin on Elevated Liver Enzymes during Statin Treatment.Drug-induced liver injury in older adults.Characteristics and clinical outcome of nonsteroidal anti-inflammatory drug-induced acute hepato-nephrotoxicity among Chinese patientsFactors affecting drug-induced liver injury: antithyroid drugs as instances.Identification of a metabolic biomarker panel in rats for prediction of acute and idiosyncratic hepatotoxicity.Cholestatic hepatitis with intravenous ceftriaxone.Trovafloxacin-induced replication stress sensitizes HepG2 cells to tumor necrosis factor-alpha-induced cytotoxicity mediated by extracellular signal-regulated kinase and ataxia telangiectasia and Rad3-relatedDrug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance StudyCorrelations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidityWITHDRAWN--a resource for withdrawn and discontinued drugsEstrium Whey induced hepatitis in a patient with metastatic breast cancer: Case report.The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics researchAcute hepatitis in a young woman with systemic lupus erythematosus: a diagnostic challenge.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Practical guidelines for diagnosis and early management of drug-induced liver injury.Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models.Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction.Biomarkers for drug-induced liver injury.Consistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity.Pharmacogenomics and adverse drug reactions: the case of statins.The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury.Hepatotoxicity: a scheme for generating chemical categories for read-across, structural alerts and insights into mechanism(s) of action.Idiosyncratic drug-induced liver injury: an update on the 2007 overview.Female gender as a susceptibility factor for drug-induced liver injury.Chimeric rodents with humanized liver: bridging the preclinical/clinical trial gap in ADME/toxicity studies.Flupirtine-induced liver injury--seven cases from the Berlin Case-control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database.Toxicophores, reactive metabolites and drug safety: when is it a cause for concern?MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humans.Cholestatic hepatic injury associated with vismodegib, aspirin, and naproxen use: a case study and review of vismodegib safety.Non-traditional dosing of statins in statin-intolerant patients-is it worth a try?Predicting acute complicated glyphosate intoxication in the emergency department.Unraveling cellular pathways contributing to drug-induced liver injury by dynamical modeling.Mechanisms Involved in Toxicity of Liver Caused by Piroxicam in Mice and Protective Effects of Leaf Extract of Hibiscus rosa-sinensis L.
P2860
Q26781923-905C07D0-AE3E-4031-B223-218A6AFDD1CFQ26824391-90B3560C-DF58-4ED3-BE2B-EC00F14E18D8Q26824754-2FCF2868-64C3-4FC4-A014-2BD62770D2A7Q28075382-BA85C2C1-D096-4A7E-AC26-7A354C505789Q28540884-8970683B-3387-47AC-A1FD-FA05AAEAC9B4Q28648515-01D74B35-7CB4-4D69-8313-5D5B7F76B431Q33590645-AD9DA60B-1EB7-4DB8-97C3-5E81F5E956A4Q33786661-652285A8-6E59-45B2-9DBA-127C9DC11148Q33949227-092125F2-9B4C-484C-BA19-58C051DF8EADQ34326687-11E83ABA-60D7-404A-ADB8-9D22D4484B49Q34339590-2D7CF2FF-FA8C-4A5D-B7A4-46F27EB7042FQ34376979-E2D38016-CA02-4280-81C6-BC2FE6F14AC5Q35157125-D726B226-1958-49C8-86E6-9EEDA80B1A3BQ35651970-3F7F3671-9340-41B1-B61B-009E9EF266DCQ35684831-BD0F3361-BE47-4009-A6F0-2A8863E29378Q36063283-B92A2026-C74D-4187-8A79-0289A5ACB285Q36434790-DFBE07D1-FADC-451A-ACAB-B8CCCED1F78DQ36561602-3375D026-BAC1-41D1-A591-68844CB86900Q36667345-13B44C2D-8B82-4FBB-A837-BAB252BBA94CQ36820752-B7CBDD4C-B3D6-408D-A21D-89E8E862FBE9Q37121662-0C36AF74-A749-4307-8683-645348D6527AQ37341906-87229813-6E51-4559-B0FC-27BCA7E66E7FQ37391731-EE700DB5-C372-47E8-80BA-B449FF496584Q37411993-3068E7D4-FCB8-4604-8931-990302FA0E86Q37720754-968CBF5F-DD1A-45FA-9662-38A87DF8CA2DQ37847121-877E2AFC-877B-41AB-9BAD-B890F85C45F2Q37875115-4BB986F2-6E8E-4A5E-81A7-544361F87411Q37979858-97684A08-776F-4847-90E4-9722125A34B1Q38123214-FB42442A-EBC7-4A14-BDE1-3DBDD4AEA97CQ38145274-EB44FDEC-FF87-43B1-A1F8-5255DF241322Q38168331-41D78354-AE7D-4178-80F4-1443AF307326Q38169790-B3547FF8-E4C6-4B56-B966-BF107265F4D2Q38173690-2583AC7F-7865-4322-884C-90C4DDF0AC96Q38177342-FBBF3946-8FAE-4AED-B394-6080EC4625A2Q38201510-1EF4428B-39E2-454C-BC85-6F6D5CC07F1DQ38231365-AE556D95-96EF-44FB-8361-12ADC5F79CD7Q38272551-27B1242E-88CA-43AC-90EF-EC1CED7B2BACQ38481601-5B87D02C-7E55-4F20-8FFB-477F337ACF52Q38949729-0DDC5EE1-C4D5-4CC7-A905-27D04987E9C9Q39177444-78BC3BC9-A3B4-4A2C-90F0-93C33623B360
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Idiosyncratic drug-induced liver injury: an overview.
@en
type
label
Idiosyncratic drug-induced liver injury: an overview.
@en
prefLabel
Idiosyncratic drug-induced liver injury: an overview.
@en
P2860
P356
P1476
Idiosyncratic drug-induced liver injury: an overview.
@en
P2093
Elizabeth A Farrington
S Hyder Hussaini
P2860
P304
P356
10.1517/14740338.6.6.673
P407
P577
2007-11-01T00:00:00Z